Craig-Hallum on Cardiff Oncology (CRDF): KOL Event Reinforces FOLFIRI Synergy

March 26, 2026 11:04 AM

Craig-Hallum analyst Albert Lowe reiterated a Buy rating and $10.00 price target on Cardiff Oncology (NASDAQ: CRDF)The analyst commented, "CRDF ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found